Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Squamous Non-Small Cell Lung Cancer Pipeline Review Report H2 2015 | ||
By: PR Newswire Association LLC. - 07 Oct 2015 | Back to overview list |
|
NEW YORK, Oct. 7, 2015 /PRNewswire-iReach/ -- ACCESS REPORT @ Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 Summary 'Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015', provides an overview of the Squamous Non-Small Cell Lung Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Squamous Non-Small Cell Lung Cancer and special features on late-stage and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. AVAIL SAMPLE @ Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 SCOPE - The report provides a snapshot of the global therapeutic landscape of Squamous Non-Small Cell Lung Cancer KEYPOINTS - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies LEAVE YOUR QUERIES @ Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 Media Contact: Norah Trent, WiseGuy Reports, +1 646 845 9349, sales@wiseguyreports.com News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WiseGuy Reports |
||
|
||
Copyright 2015 PR Newswire Association LLC. | Back to overview list |